ProPhase Labs, a biotech firm exploring a crypto treasury strategy, has placed its three units under Chapter 11 bankruptcy.
The public company has been looking for a way to collect on accounts receivables from its work in New York tents.
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
ProPhase Labs (PRPH) entered into an agreement relating to potential advisory services. Management continues to evaluate a range of options for ...
ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re ...
ProPhase Labs, Inc. (PRPH) shares ended the last trading session 8.5% higher at $8.42. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, when ...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might ...
ProPhase Labs, Inc. PRPH -7.75% ( www.ProPhaseLabs.com ) announced today that it previously received an unsolicited, non-binding proposal from Matrixx Initiatives, Inc. (“Matrixx”) to acquire the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback